Risk factors of recurrent ischemic events after acute noncardiogenic ischemic stroke.
A considerable proportion of acute noncardiogenic ischemic stroke patients continue to experience recurrent ischemic events after standard therapy. We aimed to identify risk factors for recurrent ischemic event prediction at an early stage. 286 non-cardioembolic ischemic stroke patients with onset of symptoms less than three days were enrolled. Vascular risk factors, routine laboratory data on admission, thromboelastography test seven days after clopidogrel therapy and any recurrent events within one year were assessed. Recurrent ischemic events were observed in 43 patients. The risk of recurrent ischemic event was determined by receiver operating characteristic curve and multivariable logistic regression analysis. The mean levels of mean platelet volume (MPV), platelet/lymphocyte ratio (PLR), lymphocyte count (LY) and fibrinogen (Fib) on admission were significantly higher in the case group as compared to the control group (P<0.001). Seven days after clopidogrel therapy, the ADP-induced platelet aggregation ratio (ADP%) level was lower in case group, while the maximum amplitude (MA) level was higher in case group as compared to control group (P<0.01). The area under the curve of receiver operating characteristic curve of LY, PLR, , Fib, MA, ADP% and MPV were 0.602, 0.614, 0.629, 0.770, 0.800 and 0.808, respectively. The logistic regression analysis showed that MPV, ADP% and MA were indeed predictive factors. MPV, ADP% and MA were risk factors of recurrent ischemic events after acute noncardiogenic ischemic stroke. Urgent assessment and individual drug therapy should be offered to these patients as soon as possible.